Non-toxic curative option for patients with genetic disorders
Lancet
.
2025 Dec 21;404(10471):2490-2491.
doi: 10.1016/S0140-6736(24)02301-8.
Epub 2024 Dec 3.
Author
Denis Claude Roy
1
Affiliation
1
University Institute for Hematology-Oncology and Cell Therapy, Hopital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada; Department of Medicine, Université de Montréal, Montreal, QC, Canada. Electronic address:
[email protected]
.
PMID:
39642903
DOI:
10.1016/S0140-6736(24)02301-8
No abstract available